Therefore, based on this initial infection process, the inhibitors that block the attachment or fusion process are collectively termed “entry inhibitors” and can act on the glycoproteins (gp120 and gp41), and receptors and coreceptors present on the host cell surface (CD4 and CCR5 or CXCR4). The gene discussed is CD4; the disease is infection.